{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:09:31Z","timestamp":1759666171897},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.lpm.2016.11.008","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T14:31:50Z","timestamp":1485181910000},"page":"210-217","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P1","title":["Autres syndromes parkinsoniens"],"prefix":"10.1016","volume":"46","author":[{"given":"Christine","family":"Tranchant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lpm.2016.11.008_bib0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1212115","article-title":"Mutations in COQ2\u00a0in familial and sporadic multiple system atrophy","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lpm.2016.11.008_bib0190","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","article-title":"The natural history of multiple system atrophy: a prospective European cohort study","volume":"12","author":"Wenning","year":"2013","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.lpm.2016.11.008_bib0195","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1474-4422(09)70288-1","article-title":"Multiple system atrophy: an update","volume":"8","author":"Stefanova","year":"2009","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.lpm.2016.11.008_bib0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.lpm.2016.11.008_bib0205","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/mds.22413","article-title":"Proposed neuroimaging criteria for the diagnosis of multiple system atrophy","volume":"24","author":"Brooks","year":"2009","journal-title":"Mov Disord"},{"issue":"9","key":"10.1016\/j.lpm.2016.11.008_bib0210","first-page":"2238","article-title":"Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T","volume":"26","author":"Lee","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.lpm.2016.11.008_bib0215","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.lpm.2016.11.008_bib0220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mds.26377","article-title":"Active immunization therapies for Parkinson's disease and multiple system atrophy","volume":"31","author":"Schneeberger","year":"2016","journal-title":"Mov Disord"},{"issue":"10004","key":"10.1016\/j.lpm.2016.11.008_bib0225","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.lpm.2016.11.008_bib0230","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/jnnp.2009.189142","article-title":"A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohort","volume":"81","author":"Perez","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.lpm.2016.11.008_bib0235","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Consortium on DLB Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.lpm.2016.11.008_bib0240","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2016.11.008_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski Syndrome): report of the NINDS-SPSP International Workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2016.11.008_bib0250","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroimage.2003.09.070","article-title":"Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration","volume":"21","author":"Gr\u00f6schel","year":"2004","journal-title":"NeuroImage"},{"key":"10.1016\/j.lpm.2016.11.008_bib0255","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.lpm.2016.11.008_bib0260","doi-asserted-by":"crossref","first-page":"S336","DOI":"10.1016\/S1353-8020(08)70027-0","article-title":"The many faces of corticobasal degeneration","volume":"13","author":"Wadia","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.lpm.2016.11.008_bib0265","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.lpm.2016.11.008_bib0270","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1097\/RLU.0b013e31824c5f0e","article-title":"A case of Creutzfeldt-Jakob disease mimicking corticobasal degeneration: FDG PET, SPECT, and MRI findings","volume":"37","author":"Zhang","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.lpm.2016.11.008_bib0275","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3233\/JPD-150625","article-title":"Progressive dopamine transporter binding loss in autopsy-confirmed corticobasal degeneration","volume":"5","author":"Pirker","year":"2015","journal-title":"J Parkinsons Dis"},{"issue":"12","key":"10.1016\/j.lpm.2016.11.008_bib0280","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/mds.23828","article-title":"Drug-induced parkinsonism: a review of 17\u00a0years\u2019 experience in a regional pharmacovigilance center in France","volume":"26","author":"Bondon-Guitton","year":"2011","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.lpm.2016.11.008_bib0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11598540-000000000-00000","article-title":"Drug-induced parkinsonism in the elderly: incidence, management and prevention","volume":"29","author":"L\u00f3pez-Send\u00f3n","year":"2012","journal-title":"Drugs Aging"},{"issue":"1\u20132","key":"10.1016\/j.lpm.2016.11.008_bib0290","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jns.2006.05.026","article-title":"Vascular parkinsonism\u00a0\u2013\u00a0an update","volume":"248","author":"Rektor","year":"2006","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.lpm.2016.11.008_bib0295","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mds.22937","article-title":"Differentiating vascular parkinsonism from idiopathic Parkinson's disease: asystematic review","volume":"25","author":"Kalra","year":"2010","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.lpm.2016.11.008_bib0300","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10143-012-0386-1","article-title":"Parkinsonism secondary to subdural haematoma","volume":"35","author":"Gelabert-Gonzalez","year":"2012","journal-title":"Neurosurg Rev"},{"issue":"1","key":"10.1016\/j.lpm.2016.11.008_bib0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","article-title":"Wilson's disease and other neurological copper disorders","volume":"14","author":"Bandmann","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2016.11.008_bib0310","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/WNL.0b013e3182a95883","article-title":"Extensive striatal, cortical, and white matter brain MRI abnormalities in Wilson disease","volume":"81","author":"Trocello","year":"2013","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.lpm.2016.11.008_bib0315","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/mds.25229","article-title":"Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature review","volume":"27","author":"Rubio-Agusti","year":"2012","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.lpm.2016.11.008_bib0320","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.23651","article-title":"Parkinson's syndrome and Parkinson's disease in mitochondrial disorders","volume":"26","author":"Finsterer","year":"2011","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.lpm.2016.11.008_bib0325","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/mds.20593","article-title":"Dystonia and parkinsonism in GM1\u00a0type 3\u00a0gangliosidosis","volume":"20","author":"Roze","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.lpm.2016.11.008_bib0330","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.lpm.2016.11.008_bib0335","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","article-title":"FXTAS: new insights and the need for revised diagnostic criteria","volume":"79","author":"Apartis","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.lpm.2016.11.008_bib0340","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0033-1359314","article-title":"Prion diseases","volume":"33","author":"Takada","year":"2013","journal-title":"Semin Neurol"},{"issue":"3","key":"10.1016\/j.lpm.2016.11.008_bib0345","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10048-014-0404-2","article-title":"Overall mutational spectrum of SLC20A2, PDGFB and PDGFRB in idiopathic basal ganglia calcification","volume":"15","author":"Nicolas","year":"2014","journal-title":"Neurogenetics"},{"issue":"6","key":"10.1016\/j.lpm.2016.11.008_bib0350","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng.3289","article-title":"Mutations in XPR1\u00a0cause primary familial brain calcification associated with altered phosphate export","volume":"47","author":"Legati","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2016.11.008_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14802\/jmd.14034","article-title":"Neurodegeneration with brain iron accumulation: diagnosis and management","volume":"1","author":"Hogarth","year":"2015","journal-title":"J Mov Disord"},{"issue":"1","key":"10.1016\/j.lpm.2016.11.008_bib0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa020817","article-title":"Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome","volume":"348","author":"Hayflick","year":"2003","journal-title":"N Engl J Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216303591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216303591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T22:54:20Z","timestamp":1536101660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498216303591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0755498216303591"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2016.11.008","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autres syndromes parkinsoniens","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}